P082 CBCSG-10, the addition of capecitabine to adjuvant chemotherapy in triple-negative breast cancer
P082 CBCSG-10, the addition of capecitabine to adjuvant chemotherapy in triple-negative breast cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does P082 CBCSG-10, the addition of capecitabine to adjuvant chemotherapy in triple-negative breast cancer have?
P082 CBCSG-10, the addition of capecitabine to adjuvant chemotherapy in triple-negative breast cancer has 1 citations in the OpenAlex counts ScholarIQ stores.
When was P082 CBCSG-10, the addition of capecitabine to adjuvant chemotherapy in triple-negative breast cancer published?
P082 CBCSG-10, the addition of capecitabine to adjuvant chemotherapy in triple-negative breast cancer has 2015 year in the ScholarIQ index.
What is the open-access status of P082 CBCSG-10, the addition of capecitabine to adjuvant chemotherapy in triple-negative breast cancer?
P082 CBCSG-10, the addition of capecitabine to adjuvant chemotherapy in triple-negative breast cancer has hybrid oa status in the ScholarIQ index.
What is the DOI of P082 CBCSG-10, the addition of capecitabine to adjuvant chemotherapy in triple-negative breast cancer?
The DOI for P082 CBCSG-10, the addition of capecitabine to adjuvant chemotherapy in triple-negative breast cancer is on the source record.
What is the OpenAlex record for P082 CBCSG-10, the addition of capecitabine to adjuvant chemotherapy in triple-negative breast cancer?
The OpenAlex for P082 CBCSG-10, the addition of capecitabine to adjuvant chemotherapy in triple-negative breast cancer is on the source record.